These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 27684981)

  • 1. Survey of Irradiation Practice for the Prevention of Transfusion-Associated Graft-versus-Host Disease.
    Pritchard AE; Shaz BH
    Arch Pathol Lab Med; 2016 Oct; 140(10):1092-7. PubMed ID: 27684981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transfusion-associated graft-versus-host disease: historical perspectives, incidence, and current use of irradiated blood products.
    Greenbaum BH
    J Clin Oncol; 1991 Oct; 9(10):1889-902. PubMed ID: 1919639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of post-transfusion graft-versus-host disease.
    Tasaki T; Ohto H; Abe R
    Fukushima J Med Sci; 1993 Dec; 39(2):109-11. PubMed ID: 7927133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irradiated blood products to prevent graft-versus-host disease.
    Whiteley AB
    J Clin Oncol; 1992 Mar; 10(3):506. PubMed ID: 1740686
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prevention of post-transfusion graft versus host disease by irradiating blood products with X-ray or gamma-ray].
    Tanaka S
    Nihon Rinsho; 1997 Sep; 55(9):2277-81. PubMed ID: 9301290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Progress in the field of hematology in the last 100 years: Clinical guidelines for irradiation of blood to prevent graft-versus-host disease following blood transfusion].
    Ito K
    Nihon Naika Gakkai Zasshi; 2002 Jul; 91(7):2161-8. PubMed ID: 12187692
    [No Abstract]   [Full Text] [Related]  

  • 7. [Transfusion-associated graft-vs-host disease].
    Lillevang ST; Kristensen T
    Ugeskr Laeger; 1992 Oct; 154(43):2964-8. PubMed ID: 1462384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of irradiated blood components: practice parameter.
    Przepiorka D; LeParc GF; Stovall MA; Werch J; Lichtiger B
    Am J Clin Pathol; 1996 Jul; 106(1):6-11. PubMed ID: 8701934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guidelines for irradiation of blood and blood components to prevent post-transfusion graft-vs.-host disease in Japan.
    Asai T; Inaba S; Ohto H; Osada K; Suzuki G; Takahashi K; Tadokoro K; Minami M
    Transfus Med; 2000 Dec; 10(4):315-20. PubMed ID: 11123816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of whole blood with riboflavin plus ultraviolet light, an alternative to gamma irradiation in the prevention of transfusion-associated graft-versus-host disease?
    Fast LD; Nevola M; Tavares J; Reddy HL; Goodrich RP; Marschner S
    Transfusion; 2013 Feb; 53(2):373-81. PubMed ID: 22612327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfusion-associated graft-versus-host disease.
    Dwyre DM; Holland PV
    Vox Sang; 2008 Aug; 95(2):85-93. PubMed ID: 18544121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfusion-associated graft versus host disease in the immunocompetent patient: an ongoing problem.
    Jawa RS; Young DH; Stothert JC; Kulaylat MN; Landmark JD
    J Intensive Care Med; 2015 Mar; 30(3):123-30. PubMed ID: 23792801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of 66 patients definitive with transfusion-associated graft-versus-host disease and the effect of universal irradiation of blood.
    Uchida S; Tadokoro K; Takahashi M; Yahagi H; Satake M; Juji T
    Transfus Med; 2013 Dec; 23(6):416-22. PubMed ID: 24274074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevention of posttransfusion graft-versus-host disease by leukocyte depletion filter].
    Handa M
    Nihon Rinsho; 1997 Sep; 55(9):2282-9. PubMed ID: 9301291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Transfusion-associated graft-versus-host disease. Increased risk when using HLA matched donors].
    Hovdenes J; Solheim BG
    Tidsskr Nor Laegeforen; 1995 May; 115(12):1499-501. PubMed ID: 7770854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fulminant transfusion-associated graft-versus-host disease in a premature infant.
    Berger RS; Dixon SL
    J Am Acad Dermatol; 1989 May; 20(5 Pt 2):945-50. PubMed ID: 2715450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Institution and significance of the new guidelines for prevention of transfusion associated graft versus host disease].
    Asai T
    Nihon Rinsho; 1997 Sep; 55(9):2296-304. PubMed ID: 9301293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guidelines on gamma irradiation of blood components for the prevention of transfusion-associated graft-versus-host disease. BCSH Blood Transfusion Task Force.
    Transfus Med; 1996 Sep; 6(3):261-71. PubMed ID: 8885157
    [No Abstract]   [Full Text] [Related]  

  • 19. Transfusion-associated graft-versus-host disease reexamined: potential for improved prevention using a universally applied intervention.
    Kleinman S; Stassinopoulos A
    Transfusion; 2018 Nov; 58(11):2545-2563. PubMed ID: 30267423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Graft-versus-host disease: introduction and prospect.
    Ohto H; Suzuki H; Abe R
    Fukushima J Med Sci; 1993 Dec; 39(2):63-7. PubMed ID: 7927136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.